News

Category: DIAN-TU Announcement

Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - FEB 10 2020

Major Alzheimer’s study to open 5 new Latin American sites

Washington University School of Medicine news release - Nov 20 2019

Update on the DIAN-TU-001 TRIAL

Update on the DIAN-TU-001 TRIAL:  Janssen BACE Inhibitor (JNJ-54861911/atabecestat) DRUG ARM DISCONTINUATION The statement below is an update to the...

DIAN-TU Trial Interim Analysis

Notice to DIAN-TU Investigational Sites and Participants RE: DIAN-TU-001 INTERIM ANALYSIS April 25, 2018 DIAN-TU Site Leaders and Participants, The...

Important announcement from the DIAN-TU regarding Janssen BACE inhibitor

Janssen website

DIAN-TU’s Alzheimer’s prevention trial opens enrollment to third drug

DIAN-TU open enrollment announcement

Investigational drugs chosen for major Alzheimer’s prevention trial

The Source, Washington University in St. Louis - October 10, 2012